Global Anorectal Disorders Treatment Market Expected To Grow Steadily During The Forecast Period

The global anorectal disorders treatment market size was worth around USD 3.89 billion in 2022 and is predicted to grow to around USD 6.13  billion by 2030 with a compound annual growth rate (CAGR) of roughly 5.85% between 2023 and 2030.

Anorectal disorders are a range of medical conditions that affect the anus and rectum of patients. These conditions are known to cause severe discomfort, itching, bleeding, pain, and other symptoms around the anal or rectal area. The several types of disorders associated with anorectal conditions can severely cause damage to the emotional well-being of the patient along with physical health. It diminishes the quality of life due to the social stigma associated with these conditions. The anorectal disorders treatment market deals with medication and therapies that are used for the treatment of anorectal disorders which varies depending on the exact condition. It also deals with timely diagnosis, symptom management, treatment, and post-surgical care that patients have to undertake while being treated. During the forecast period, the industry outlook is projected to be positive.

This review is based on a report by Zion Market Research, titled "Anorectal Disorders Treatment Market By End-Users (Specialty Clinics, Hospitals, And Others), By Disease (Rectal Prolapse, Hemorrhoid, Diarrhea, Abscess, Fistula, Fissures, Itching, Warts, Others), By Route Of Administration (Rectal, Parenteral, Oral, And Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030"- Report at https://www.zionmarketresearch.com/report/anorectal-disorders-treatment-market

The global anorectal disorders treatment market is expected to grow owing to the aging population across the globe. Elderly people are more prone to contracting certain types of anorectal disorders due to factors such as weakened muscles, decreased tissue elasticity, and a higher incidence of chronic conditions. All of these issues are age-related and with the growing geriatric population worldwide, the demand for anorectal disorders treatment is expected to continue generating higher revenue. In addition to this, the increasing investment in technological advancements directed toward diagnostic tools and surgical equipment could also result in a positive trend. Some examples include laser treatments, minimally invasive techniques, and novel surgical procedures are reasons why more patients can be expected to be treated effectively in the coming years.

The rise in sedentary lifestyles, especially post Covid-19 due to the growing remote work culture is also a leading cause of a growing number of anorectal disorders in addition to poor lifestyle choices and eating habits. Other factors such as growing health infrastructure, increasing emphasis on patient awareness and reimbursement for the poor section of the society, and increased demand for quality medical care are expected to play crucial roles in the growth period.

The anorectal disorders treatment industry can expect certain growth restrictions owing to the large-scale adoption of conservative treatment methods over more effective medically-backed measures to treat the conditions. Some patients may prefer self-care and bring changes to lifestyle or eating habits rather than undertaking medical intervention. Furthermore, the associated risks of treatment and side effects push more people toward conservative or home remedies. This is especially applicable to surgical procedures.

The increasing efforts undertaken by healthcare agencies may provide growth opportunities while the limited reimbursement policies could challenge market expansion.

The global anorectal disorders treatment market is segmented based on end-users, diseases, route of administration, distribution channel, and region.

Based on end-users, the global market segments are specialty clinics, hospitals, and others.

Based on disease, the global market segments are rectal prolapse, hemorrhoid, diarrhea, abscess, fistula, fissures, itching, warts, and others. The anorectal disorders treatment industry registered the highest growth in the hemorrhoid segment in 2022 since it is one of the most commonly occurring or most widely reported anorectal disorders. Some common symptoms associated with the condition are pain, itching, bleeding, and discomfort during bowel movements. Factors like pregnancy, obesity, and chronic constipation are the main reasons for the onset of the condition. A recent study suggests that nearly 50% of the US population over the age of 50 years has suffered from hemorrhoids, as quoted by the National Library of Medicine.

Based on route of administration, the anorectal disorders treatment industry divisions are rectal, parenteral, oral, and others.

Based on distribution channel, the global market segments are retail pharmacy, hospital pharmacy, and others. 2022 registered the highest growth in the retail pharmacy segment, especially for over-the-counter (OTC) medication used for the treatment of hemorrhoids. Retail pharmacies operate independently or they are chain drug stores that are easily accessible to the general population. They include a wide range of branded or generic medicine and hence are most preferred in the consumer group. They generally cater to the needs of patients who require self-medication. The Commonwealth Fund estimates that out of 60,000 retail pharmacies in the US, at least one-third are independent pharmacies.

The global anorectal disorders treatment market is expected to witness the highest growth in North America with the US acting as the dominant shareholder. The market growth is anticipated to be driven by the presence of key industry players in terms of drug and medical device development. Moreover, the high awareness rate and favorable reimbursement policies may play a crucial role in pushing the regional market further. In Europe, the growth may be a result of the increasing elderly population along with the growing prevalence of the condition. Countries such as Germany, the United Kingdom, France, and Italy have established healthcare infrastructure which may promote better growth in the coming years. Factors such as a growing population, increasing disposable income, and a rise in healthcare investments are projected to drive the market in Asia-Pacific.

Recent Developments:

• In March 2023, PharmEasy posted an explanatory article on exercises that can be undertaken to treat painful fissures. The article was medically reviewed by Dr. Shiv Kishor
• In January 2023, French President Emmanuel Macron announced that the government would be undertaking a series of investments in the national healthcare sector. The decision was influenced by the strikes initiated by general practitioners demanding consultation fees to be increased from €25 to €50       

Anorectal Disorders Treatment Market: Competitive Analysis

The global anorectal disorders treatment market is led by players like:

• Johnson & Johnson
• Medtronic
• Boston Scientific Corporation
• Pfizer Inc.
• Allergan plc (AbbVie)
• Cook Medical Inc.
• Olympus Corporation
• Teleflex Incorporated
• B. Braun Melsungen AG
• Salix Pharmaceuticals (a subsidiary of Bausch Health Companies Inc.)
• Coloplast A/S
• ConvaTec Group PLC
• Ethicon (a subsidiary of Johnson & Johnson)
• GlaxoSmithKline PLC
• Novartis AG
• Pfizer Inc.
• Takeda Pharmaceutical Company Limited
• Ferring Pharmaceuticals
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd.
• Abbott Laboratories
• Cardinal Health Inc.
• McKesson Corporation
• AmerisourceBergen Corporation
• Cigna Corporation.

The global anorectal disorders treatment market is segmented as follows:

By End-Users

• Specialty Clinics
• Hospitals
• Others

By Disease

• Rectal Prolapse
• Hemorrhoid
• Diarrhea
• Abscess
• Fistula
• Fissures
• Itching
• Warts
• Others

By Route of Administration

• Rectal
• Parenteral
• Oral
• Others

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of The Middle East & Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com